Brief: Dancann Pharma A/S Enter Exclusive Agreement With Cannassure Therapeutics
15/12/2020 07:05
Dec 15 (Reuters) - Dancann Pharma A/S DANCAN.TE :
* DANCANN PHARMA A/S ENTER EXCLUSIVE AGREEMENT WITH CANNASSURE THERAPEUTICS TO BE
MULTINATIONAL
DISTRIBUTOR FOR SCANDINAVIA (DENMARK, NORWAY, SWEDEN, AND FINLAND)
* DANCANN PHARMA A/S - DANCANN PHARMA WILL SUBMIT ITS FIRST PRODUCT APPROVAL APPLICATION TO
DANISH
MEDICINES AGENCY FOR DISTRIBUTION AGREEMENT IN BEGINNING OF 2021 TO HAVE PRODUCTS APPROVED FOR
DANISH MEDICAL CANNABIS PILOT PROGRAMME.
Source text for Eikon: ID:nWkr7zQBs
Further company coverage: DANCAN.TE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Dancann Pharma A/S
See all newsBrief: Dancann Pharma Says Jeppe Krog Rasmussen Resigns As CEO
Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874